相关实验视频
Updated: Jun 25, 2025
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
75
后COVID-19 炎症性风湿性关节炎 缓解
11Cancer Medicine, National Hospital Organization Kyoto Medical Center, Kyoto-city, Kyoto 612-8555; 2Medical R&D Promotion Project, The Japan Agency for Medical Research and Development (AMED), Chuo-ku, Tokyo 103-0022, Japan.
Georgian medical news
|May 29, 2024
概括
COVID-19 感染增加了自身免疫性类风湿性疾病的风险. 后COVID-19炎症性关节炎不同于传统的类风湿性关节炎,这表明新的缓解重点治疗是可能的.
科学领域:
- 类风湿病学 类风湿病学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 严重急性呼吸道综合征冠状病毒-2 (SARS-CoV-2) 感染与自身免疫性炎症性类风湿性疾病的风险增加有关.
- 虽然细菌感染可以引发类风湿性关节炎,但病毒感染很少这样做. 自身免疫性类风湿性关节炎通常影响成年女性比男性更多,并且涉及遗传因素.
- 目前用于类风湿性关节炎的治疗方法,包括类固醇和生物药物 (抗瘤缩因子-α,抗干白素-6),可以缓解症状,但不能治愈潜在的病理.
研究的目的:
- 与传统的自身免疫性类风湿性关节炎相比,研究与COVID-19相关的炎症性类风湿性关节炎的独特特征.
- 探索开发旨在实现COVID-19相关炎症性关节炎缓解的新疗法的潜力.
主要方法:
- 对由感染引发的类风湿性关节炎的临床研究进行比较分析.
- 审查目前的类风湿性关节炎治疗策略及其在COVID-19相关病例中的有效性.
- 对患有COVID-19后炎症性类风湿性关节炎的患者进行病理检查.
主要成果:
- 与COVID-19相关的炎症性类风湿性关节炎与自身免疫性类风湿性关节炎相比,似乎具有不同的发病,症状和病理发现.
- 类固醇免疫抑制治疗显示对与COVID-19相关的炎症性类风湿关节炎的有效性.
- 与COVID-19相关的自身免疫性疾病可能具有与遗传自身免疫性疾病不同的病理状况.
结论:
- 与COVID-19相关的炎症性类风湿性关节炎的独特病理表明,针对缓解的治疗是一种可行的治疗策略.
- 进一步的病理分析对于开发有效治疗COVID-19后炎症性类风湿关节炎至关重要.
- 了解COVID-19相关性和自身免疫性类风湿性关节炎之间的差异是促进类风湿病护理的关键.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
131
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131
01:28Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158
01:20The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115